BNTX - BioNTech SE
95.03
0.890 0.937%
Share volume: 765,939
Last Updated: 12-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$94.14
0.89
0.01%
Summary score
9%
Profitability
0%
Dept financing
12%
Liquidity
74%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.17%
Return on assets
-8.16%
Return on sales
-204.65%
Return on invested capital
-53.4%
Total debt ratio
38.48%
Debt ratio change over timeo
0%
Current Ratio
3.17%
Quick Ratio
3.11%
Cash Position Ratio
2.96%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.17%
Return on assets
-8.16%
Return on sales
-204.65%
Return on invested capital
-53.4%
Total debt ratio
38.48%
Debt ratio change over timeo
0%
Current Ratio
3.17%
Quick Ratio
3.11%
Cash Position Ratio
2.96%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.38%
Return on assets
-8.15%
Return on sales
-193.85%
Return on invested capital
-55.98%
Total debt ratio
38.16%
Debt ratio change over time
0%
Current Ratio
2.93%
Quick Ratio
2.88%
Cash Position Ratio
2.75%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BNTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -13.17% | 11.55% | 5.76% | 8.53% |
| Return on assets | -8.16% | 3.57% | 4.02% | 5.96% |
| Return on sales | -204.65% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | -53.4% | 7.99% | 5.61% | 8.26% |
| Profitability | 0% | 87% | 68% | 93% |
| Total debt ratio | 38.48% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 13% | 25% | 47% | 17% |
| Current Ratio | 3.17% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 3.11% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 2.96% | 0.76% | 2.25% | 1% |
| Liquididy | 71% | 55% | 60% | 41% |
| Short-term ratios | BNTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -13.17% | 17.94% | -1.29% | 11.66% |
| Return on assets | -8.16% | 3.67% | 1.51% | 6.9% |
| Return on sales | -204.65% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | -53.4% | 7.17% | -0.65% | 10.66% |
| Profitability | 0% | 74% | 14% | 91% |
| Total debt ratio | 38.48% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 12% | 25% | 30% | 41% |
| Current Ratio | 3.17% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 3.11% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 2.96% | 0.76% | 2.25% | 1% |
| Liquididy | 75% | 36% | 64% | 38% |